ClinicalTrials.gg
Active, not recruitingNCT04508322Updated Aug 17, 2025

Treatment of Class II Malocclusion With Excessive Overjet

An interventional study of HGA and FA in Class II Malocclusion, Division 1, Orthodontic Appliances and Quality of Life, sponsored by Jenny Kallunki. Active, not recruiting at 1 site in Sweden. Open to participants aged 8 Years to 10 Years. Per ClinicalTrials.gov, last updated 2025-08-17.

Sponsored by Jenny Kallunki · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 years 8 months after the study started (first participant enrolled Dec 2013, registered Aug 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
96
Allocation
Randomized
Ages
8 Years to 10 Years
Sex
All
01

Study summary

Class II malocclusion with excessive overjet is one of the most common malocclusions among children and adolescents. The overall goal of the project is to analyze orthodontic treatment of Class II malocclusion with excessive overjet when the treatment is started in different ages and treated with removable and/or fixed appliance.

Treatment initiated before the age of eleven is performed with a removable functional appliance, Headgear Activator (HGA). Treatment starting in early adolescence is performed with fixed orthodontic appliance (FA).

The hypotheses are:

  • Treatment with HGA at the age of nine or eleven is effective. No spontaneous correction of the malocclusion is expected in the untreated control group.
  • Patient experience, treatment effect and cost-effectiveness are equivalent whether the treatment with HGA is initiated at the age of nine or eleven.
  • Treatment results, patient experience and treatment- and cost-effectiveness are equivalent whether treatment is initiated early with HGA or initiated in early adolescence with FA.
  • The treatment of Class II malocclusion with excessive overjet renders long-term treatment stability and patient satisfaction.
Read the detailed description

Participants (children, 9 years of age) are recruited at the orthodontic specialist clinic in Norrköping, Sweden.

After informed consent participants are randomized into Group 1, 2 or 3. After randomization and registration, treatment with HGA is initiated for Group 1.

Group 2 and 3 serves as untreated control group. Two years after registration, Group 2 starts treatment with HGA at the age of eleven.

Group 3 serves as untreated control group to treatment with HGA.

Four years after registration, Group 3 starts treatment with FA (3M Victory brackets, .022 slot size, McLaughlin-Bennet-Trevesi prescription).

The patients in group 1 and 2 in need of a second phase of orthodontic treatment are treated with FA (3M Victory brackets, .022 slot size, McLaughlin-Bennet-Trevesi prescription) in early adolescence.

The following registrations are made:

Study models, photographs (extraoral, intraoral), Lateral head radiographs (T0, T2, T5, if required T1, T3), Child perceptions questionnaire.

T0: After randomization; before treatment start (Group 1), registration/control (Group 2,3).

T1: Two years after T0; after finished treatment for (Group 1), before treatment start (Group 2), control/registration for (Group 3).

T2: Two years after T1; follow up (Group 1), after finished treatment (Group 2), before treatment start (Group 3).

T3: Approx two years after T2 for patients not undergoing treatment with FA. For patients treated with FA, when treatment is finished.

T4: Approx two years after T3- follow up.

T5: Approx 8-10 years after T0 (Long term follow-up)

02

Conditions studied

  • Class II Malocclusion, Division 1
  • Orthodontic Appliances
  • Quality of Life
  • Costs and Cost Analysis
03

In context

Malocclusion, Angle Class II

124 studies on the registry are indexed under Malocclusion, Angle Class II; 19 are open to participants now.

This study's enrollment of 96 is above the median of 34 across 115 interventional studies indexed under Malocclusion, Angle Class II.

Browse Malocclusion, Angle Class II studies →

Lead sponsor

This is the only study on the registry with Jenny Kallunki as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Eight to ten years of age at the start of the trial
  • mixed dentition;
  • Excessive overjet (≥ 6 mm) and first maxillary permanent molars in Class II malocclusion
  • No sucking habits or ceased sucking habits should have been evident at least one year before the trial was started.

Exclusion criteria

Exclusion Criteria:

  • Craniofacial syndromes
  • Previous orthodontic treatment
  • Severe crowding of teeth, i.e. making the extraction of teeth necessary
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
96 participants (actual)

Study arms

  • Active comparator
    Group 1

    Early treatment HGA (9 years)

    Device: HGA · Device: FA

  • Active comparator
    Group 2

    Late treatment HGA (11 years)

    Device: HGA · Device: FA

  • Active comparator
    Group 3

    Treatment FA

    Device: FA

Interventions

  • DeviceHGA

    Headgear Activator

  • DeviceFA

    Fixed Orthodontic Appliance

06

What researchers measure

Primary outcomes

  1. Change in overjet; i.e change in tooth position during treatment. Assessment at follow up.

    Tooth movement is assessed in millimeters by measures on study models.

    Time frame: Through study completion (T0-T5), an average of two years between controls.

Secondary outcomes

  1. Change in Oral health related quality of life (OHRQoL)

    Oral health related quality of life is assessed by the use of the Child Perceptions Questionnaire where 0 is minimal and 148 is maximum. Higher scores corresponds to poorer OHRQoL.

    Time frame: Through study completion (T0-T5), an average of two years between controls.

  2. Societal costs

    Societal costs are the sum of indirect and direct treatment costs. Indirect treatment costs are travel costs for the patient and cost for parents when accompaning patients during treatment. Direct costs are clinical costs due to personnel and material.

    Time frame: During active treatment (T0-T3).

  3. Change in tooth position and skeletal growth.

    Tooth movement is assessed in millimeters by measures on study models. Skeletal growth is assessed in length and angular measures by cephalometric analysis of lateral radiographs.

    Time frame: Through study completion (T0-T5), an average of two years between controls.

07

Study locations

1 site
  • The Center for Orthodontics and Pedodontics
    Norrköping, Östergötland County 60182, Sweden
08

References and documents

Publications

  • Batista KB, Thiruvenkatachari B, Harrison JE, O'Brien KD. Orthodontic treatment for prominent upper front teeth (Class II malocclusion) in children and adolescents. Cochrane Database Syst Rev. 2018 Mar 13;3(3):CD003452. doi: 10.1002/14651858.CD003452.pub4. PubMed 29534303 ↗
  • Dimberg L, Arnrup K, Bondemark L. The impact of malocclusion on the quality of life among children and adolescents: a systematic review of quantitative studies. Eur J Orthod. 2015 Jun;37(3):238-47. doi: 10.1093/ejo/cju046. Epub 2014 Sep 11. PubMed 25214504 ↗
  • O'Brien K, Wright J, Conboy F, Chadwick S, Connolly I, Cook P, Birnie D, Hammond M, Harradine N, Lewis D, McDade C, Mitchell L, Murray A, O'Neill J, Read M, Robinson S, Roberts-Harry D, Sandler J, Shaw I, Berk NW. Effectiveness of early orthodontic treatment with the Twin-block appliance: a multicenter, randomized, controlled trial. Part 2: Psychosocial effects. Am J Orthod Dentofacial Orthop. 2003 Nov;124(5):488-94; discussion 494-5. doi: 10.1016/S0889540603006425. PubMed 14614414 ↗
  • Jokovic A, Locker D, Tompson B, Guyatt G. Questionnaire for measuring oral health-related quality of life in eight- to ten-year-old children. Pediatr Dent. 2004 Nov-Dec;26(6):512-8. PubMed 15646914 ↗
  • Jokovic A, Locker D, Stephens M, Kenny D, Tompson B, Guyatt G. Validity and reliability of a questionnaire for measuring child oral-health-related quality of life. J Dent Res. 2002 Jul;81(7):459-63. doi: 10.1177/154405910208100705. PubMed 12161456 ↗
  • Kallunki J, Sollenius O, Paulsson L, Petren S, Dimberg L, Bondemark L. Oral health-related quality of life among children with excessive overjet or unilateral posterior crossbite with functional shift compared to children with no or mild orthodontic treatment need. Eur J Orthod. 2019 Mar 29;41(2):111-116. doi: 10.1093/ejo/cjy033. PubMed 29878165 ↗
  • Kallunki J, Bondemark L, Paulsson L. Early headgear activator treatment of Class II malocclusion with excessive overjet: a randomized controlled trial. Eur J Orthod. 2021 Dec 1;43(6):639-647. doi: 10.1093/ejo/cjaa073. PubMed 33274388 ↗
  • Kallunki J, Bondemark L, Paulsson L. Comparisons of costs and treatment effects-an RCT on headgear activator treatment of excessive overjet in the mixed and late mixed dentition. Eur J Orthod. 2022 Jan 25;44(1):86-94. doi: 10.1093/ejo/cjab026. PubMed 34041527 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2013 (actual). Primary completion is estimated for Dec 2030, 204 months after the start.

Of 86 non-industry interventional studies with no phase under Malocclusion, Angle Class II, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 22. This study's planned 204 months is above that.

Counting every sponsor, half of 86 studies reached it within 15 months; a quarter within 11 and three quarters within 22.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 5, 2020
First posted
Aug 11, 2020
StartActual
Dec 5, 2013
Primary completionEst.
Dec 2030
CompletionEst.
Dec 2030
Last update
Aug 17, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04508322
Lead sponsor
Jenny Kallunki
Collaborators
Region Östergötland, Malmö University, Eklund foundation Malmö, Swedish Dental Associations Scientific Funds
Responsible party
Jenny Kallunki (Senior Consultant Orthodontist. PhD-student, Region Östergötland) — Sponsor-investigator
First posted
Aug 11, 2020
Start date
Dec 5, 2013
Primary completion
Dec 2030 (estimated)
Completion
Dec 2030 (estimated)
Last update
Aug 17, 2025

Study contacts

Jenny Kallunki, Orthodontist
principal investigator · Malmö University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion